rss
Gut 2009;58:530-535 doi:10.1136/gut.2008.162883
  • Colorectal cancer

Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer

  1. R J C Steele1,2,3,
  2. P L McClements4,
  3. G Libby3,4,
  4. R Black4,
  5. C Morton5,
  6. J Birrell5,
  7. N A G Mowat6,
  8. J A Wilson7,
  9. M Kenicer8,
  10. F A Carey9,
  11. C G Fraser2
  1. 1
    Department of Surgery, University of Dundee, Dundee, UK
  2. 2
    Scottish Bowel Screening Centre, UK
  3. 3
    Bowel Screening Research Unit, Scottish Bowel Screening Centre, UK
  4. 4
    Information Services, NHS National Services Scotland, UK
  5. 5
    NHS National Services Scotland, UK
  6. 6
    Department of Gastroenterology, Aberdeen Royal Infirmary, Aberdeen, UK
  7. 7
    Department of Gastroenterology, Victoria Hospital, Kirkaldy, UK
  8. 8
    Department of Public Health, NHS Tayside, Dundee, UK
  9. 9
    Department of Pathology, University of Dundee, Dundee, UK
  1. Professor R J C Steele, Department of Surgery and Molecular Oncology, Level 6, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK; r.j.c.steele{at}dundee.ac.uk
  • Revised 1 November 2008
  • Accepted 5 November 2008
  • Published Online First 26 November 2008

Abstract

Objectives: To assess the effects of the first three rounds of a pilot colorectal screening programme based on guaiac faecal occult blood testing (gFOBT) and their implications for a national population-based programme.

Methods: A demonstration pilot programme was conducted in three Scottish NHS Boards. Residents aged between 50 and 69 years registered on the Community Health Index were included in the study.

Results: In the first round, the uptake was 55.0%, the positivity rate was 2.07% and the cancer detection rate was 2.1/1000 screened. In the second round, these were 53.0%, 1.90% and 1.2/1000, respectively, and in the third round, 55.3%, 1.16% and 0.7/1000, respectively. In the first round, the positive predictive value of the gFOBT was 12.0% for cancer and 36.5% for adenoma; these fell to 7.0% and 30.3% in the second round and were maintained at 7.5% and 29.1% in the third round. The percentage of screen-detected cancers diagnosed at Dukes’ stage A was 49.2% in the first round, 40.1% in the second round and 36.3% in the third round.

Conclusions: These results are compatible with those of previous randomised trials done in research settings, demonstrating that population-based colorectal cancer screening is feasible in Scotland and should lead to a comparable reduction in disease-specific mortality.

Footnotes

  • Competing interests: None.

  • Funding: This work was supported in part by a grant from the Chief Scientist Office, Scottish Government Health Department, to establish a Bowel Screening Research Unit.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All Versions of this Article:
    1. gut.2008.162883v1
    2. 58/4/530 most recent

Social bookmarking

Latest from Gut Education

Latest from Gut Education

Register for free content


Free sample
 This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Gut.
View free sample issue >>

Free archive
The full back archive is now available for Gut. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.